Profile cover photo
Profile photo
The Oncologist
142 followers
142 followers
About
The Oncologist's posts

Post has attachment

Post has attachment
Targeted drug delays relapse of intermediate-stage lung cancer -

Post has attachment
Shorter Duration of Trastuzumab May Reduce Cardiac Toxicity, Costs | ASCO Annual Meeting http://ow.ly/cIN730cmK6G

Post has attachment

Post has attachment
FDA granted accelerated approval to brigatinib (ALUNBRIG tablets, Takeda Pharmaceutical Company Limited, through its wholly owned subsidiary ARIAD Pharmaceuticals, Inc.) for the treatment of patients with metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.

Post has attachment
FDA expanded the indications of regorafenib - http://bit.ly/2qcq8gn

Post has attachment

Post has attachment
Discussions with Don S. Dizon Blog's newest blog - What’s in a Word?

Post has attachment

Post has attachment
Wait while more posts are being loaded